中
Home
About TUL
Group Introduction
Executive Directors
Subsidiaries
Contact Us
Innovation in R&D
R&D Pipeline
R&D Platform
R&D Updates
News
TUL Highlights
Product Center
Finished Products
Comprehensive Health Products
APIs and Intermediates
Animal protection products
Empty capsule
Medical device
Cosmetic Peptide Series
Sustainability
Enhancing Governance
Normalizing Healthiness
Brand Building
People-Oriented
Green Development
ESG Reports
ESG News
Investor Relations
News
TUL Highlights
2026-09-07
UBT251 INJECTION COMPLETED FIRST PARTICIPANT DOSING IN PHASE III CLINICAL STUDY FOR OVERWEIGHT OR OBESITY IN CHINA
Learn More
2026-09-07
Significant Progress in Innovative Drug R&D and Continued Globalization Efforts Profit Attributable to Owners of the Company Reached Approximately RMB347.6 Million
Learn More
2026-08-12
FDA APPROVAL OF IND FOR THE GROUP’S PRODUCT UBT48128 TABLETS
Learn More
2026-07-15
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT SODIUM HYALURONATE EYE DROPS WITH NEW SPECIFICATION
Learn More
2026-07-03
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT TADALAFIL TABLETS
Learn More
All News
Select Year
2026
2025
2024
A new milestone in power supply! The United Laboratories (Inner Mongolia) Co., Ltd. held the commissioning ceremony for its 110KV substation
2024-12-02
TUL Participates in Pharmtech & Ingredients 2024 in Russia
2024-11-22
The United Laboratories (Inner Mongolia) Co., Ltd. Completes On-Site South Korean GMP Inspection
2024-11-21
TUL Honored as a “Low-Carbon Pioneer Among Listed Chinese Pharmaceutical Companies”
2024-11-21
TUL Participates in the 26th Academic Conference of the Chinese Diabetes Society of Chinese Medical Association
2024-11-18
TUL’s Cefuroxime Sodium for Injection Passes Generic Drug Consistency Evaluation in Quality and Efficacy
2024-11-18
TUL Participates in the 2024 Diabetes Frontier Academic Forum Organized by the Diabetes Professional Committee of Chinese Research Hospital Association
2024-11-18
The United Bio-Technology (Hengqin) Co., Ltd. Recognized as a Benchmark Project in the Biopharmaceutical and Comprehensive Health Industry of the Guangdong-Macao In-Depth Cooperation Zone in Hengqin
2024-11-18
TUL Recognized in Four Lists including “Top 100 Hong Kong Stocks”, Showcasing Its Outstanding Strength
2024-11-12
Prev
1
...
11
12
13
14
15
...
17
Next
WeChat
Official
Account
To Top